Internal Medicine, Hematology & Oncology · Clifton Springs, NY
NPI
1265482400
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
6 Ambulance Drive
Clifton Springs, NY, 14432
Phone (315) 462-1472
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
354 services
Medicare patients, 2024
102
Average age 75
Drug cost, 2024
$7.4M
1,803 prescriptions
Company payments, 2023
$432
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lynn M Sievert was code 99214 (office e&m - established), 104 times for 61 patients. In total Lynn M Sievert billed 354 services in 6 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 104 | 61 | $57.37 | $5,966 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 97 | 57 | $10.68 | $1,036 |
| 99215 Office E&M - Established | Facility | 75 | 45 | $84.92 | $6,369 |
| 99213 Office E&M - Established | Facility | 42 | 34 | $38.40 | $1,613 |
By year: 2022 $19K for 298 services; 2023 $19K for 277 services; 2024 $17K for 354 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lynn M Sievert prescribed most often to Medicare patients was Xtandi (Enzalutamide), with 204 prescriptions and refills. In total Lynn M Sievert wrote 1,803 Medicare prescriptions that cost $7.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xtandi Enzalutamide | 204 | 220 | 26 | $2.2M |
| Prednisone Generic | 126 | 151 | 35 | $585 |
| Abiraterone Acetate Generic | 118 | 134 | 22 | $537K |
| Finasteride Generic | 117 | 189 | 24 | $752 |
| Bicalutamide Generic | 107 | 155 | 23 | $1,637 |
| Levothyroxine Sodium Generic | 86 | 148 | 21 | $779 |
| Gabapentin Generic | 75 | 97 | 17 | $411 |
| Famotidine Generic | 57 | 71 | 15 | $549 |
| Nubeqa Darolutamide | 50 | 54 | Under 11 | $591K |
| Orgovyx Relugolix | 46 | 46 | Under 11 | $118K |
| Erleada Apalutamide | 46 | 46 | Under 11 | $543K |
| Trazodone Hcl Generic | 36 | 48 | Under 11 | $105 |
| Cabometyx Cabozantinib S-Malate | 35 | 35 | Under 11 | $900K |
| Omeprazole Generic | 32 | 56 | Under 11 | $321 |
| Lenvima Lenvatinib Mesylate | 30 | 30 | Under 11 | $758K |
Brand drugs: - claims; generic drugs: 1,209 claims; opioid claims: 66.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Lynn M Sievert $432 ($432 in general payments such as food, travel and fees) from 1 company. The largest payer was E.R. Squibb & Sons, L.L.C. with $432.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $432 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.